This is prospective, multi-phase, single arm, multi-centre, multi-surgeon feasibility clinical trial to provide proof of concept and clinical evidence regarding the safety and efficacy of Versius (robotic surgery medical device) in Urological Procedures in Paediatric population. In alignment with IDEAL (Idea, Development, Exploration, Assessment, Long-term study) Framework, this study will consist of 3 main phases to ensure proper procedure development while ensuring patients safety. Feasibility and safety will be assessed on an ongoing basis, and specifically after completion of the first 3 procedures, at a single site (Southampton/Lead), each conducted one week apart to allow the identification of unanticipated risks/adverse events. Once deemed safe, based on the results of the 3 cases enrolled in Phase I, 7 further cases would be completed, at the same site. Once the procedure is deemed safe according to safety data collected, the recruitment will proceed to full trial patient accrual, 140 additional cases from the 3 participating study sites.The study patient population is children and adolescents under the age of 18, which will be provided clinical care and follow-ups per standard of care and hospital's policy.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
150
Urological minimal access surgery performed with Versius Surgical System
Department of Paediatric Urology, Evelina London Children's Hospital
London, United Kingdom
NOT_YET_RECRUITINGDepartment of Paediatric Urology Royal Manchester Children's Hospital
Manchester, United Kingdom
NOT_YET_RECRUITINGDepartment of Paediatric Urology Southampton Children's Hospital
Southampton, United Kingdom
RECRUITINGAdverse Event rate
Incidence of adverse events
Time frame: Up to 3 months post operation
Procedure completion
Rate of successful completion of procedures without unplanned conversion to other laparoscopic or open surgery
Time frame: Day of operation
Serious Adverse Event Rate
Incidence of serious adverse events
Time frame: Up to 3 months post-operation
Ultrasound grading
Ultrasound hydronephrosis grading results
Time frame: 3 months post stent removal
MAG3 Renogram
MAG3 Renogram results
Time frame: 3 months post stent removal
Operative time
Surgery duration from skin incision to skin closure in minutes
Time frame: Day of operation
Blood loss
Estimated blood loss in mL
Time frame: Day of operation
Post operative analgesic treatment
Pain medication prescribed post-operatively
Time frame: Immediately after surgery
Length of stay
Hospital stay from end of surgery to discharge in days
Time frame: Up to 3 months post operation, average 1 day
Reoperation
Reoperation within 24 hours of surgery
Time frame: 24 hours post operation
Unplanned readmission
Unplanned hospital readmissions
Time frame: Up to 3 months post operation
Device deficiencies and user errors
Device deficiencies and user errors that occur during surgery
Time frame: Day of operation
Ultrasound grading
Ultrasound hydronephrosis grading results
Time frame: 12 months post operation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.